Financial Results & Limited Review Report for Sept 30, 2015 (Standalone)
Abbott India Ltd has informed BSE about the Standalone Financial Results & a copy of the Limited Review Report for the period ended September 30, 2015.06-11-2015
06-11-2015
Re-appointment of Independent Director
Abbott India Ltd has informed BSE that Mr. R A Shah, Non-Executive Director of the Company has been re-appointed as an Independent Director effective October 28, 2015 for a term upto March 31, 2019, subject to the approval of shareholders at the next Annual General Meeting.30-10-2015
Board Intimation for Results & Closure of Trading Window
Abbott India Ltd has informed BSE that a Meeting of the Board of Directors of the Company is scheduled to be held on November 06, 2015, inter alia, to consider and approve the text of Unaudited Quarterly Results of the Company for the quarter and half year ended on September 30, 2015, along with the Limited Review Report of the Auditors thereon....28-10-2015
Shareholding Pattern For September 30, 2015
Abbott India Ltd has informed BSE about the Shareholding Pattern as on September 30, 2015.18-10-2015
Abbott India Ltd reply to clarification sought by the exchange
The Exchange had sought clarification from Abbott India Ltd with respect to news appearing in Hindustan Times on October 15, 2015 titled "DCGI orders Abbott to test Phensedyl syrup."Abbott India Ltd response is enclosed.15-10-2015
Clarification sought from Abbott India Ltd
The Exchange has sought clarification from Abbott India Ltd with respect to news article appearing in Hindustan Times on October 15, 2015 titled "DCGI orders Abbott to test Phensedyl syrup." The reply is awaited.15-10-2015
Godrej Properties sells 435,000 sq. ft BKC office space for Rs1,479 crore
Pharma firm Abbott India buys the space for a new Mumbai corporate office at the Godrej BKC building30-09-2015
Clarification
With reference to increase in Volume, Abbott India Ltd has Clarified to BSE as under:"the Company does not have any unpublished information/announcement/news that is required to be disclosed under Clause 36 of the Listing Agreement."21-09-2015
Clarification Sought from Abbott India Ltd
The Exchange has sought clarification from Abbott India Ltd on September 21, 2015, with reference to increase in Volume.The reply is awaited.21-09-2015
Abbott India hits lifetime high
Post June quarter results, the stock outperformed the market by gaining 20% compared to 10% fall in the Sensex.07-09-2015